Terry Vance Enanta Pharmaceuticals Inc (ENTA) insider trading activity

ENTA Quotes by TradingView

Terry Vance is Director of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 5,800 shares of ENTA, which is worth approximately $52,258. The most recent transaction as insider was on Dec 13, 2023, when has been sold 15,295 shares (Common Stock) at a price of $9.12 per share, resulting in proceeds of $139,490. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.8K
0% 3M change
72.51% 12M change
Total Value Held $52,258

Terry Vance Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2023
SELL
Open market or private sale
$139,490 $9.12 p/Share
15,295 Reduced 72.51%
5,800 Common Stock
Mar 16 2023
BUY
Exercise of conversion of derivative security
$81,200 $14.0 p/Share
5,800 Added 21.57%
21,095 Common Stock
TV

Terry Vance

Director
Watertown, MA

Track Institutional and Insider Activities on ENTA

Follow ENANTA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

News

Receive news related to ENANTA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ENTA